NIH-funded research R01 grant

Investigating the role of mitochondria in eosinophilic esophagitis

Official title: Mitochondria in eosinophilic esophagitis pathogenesis

Funded at Temple Univ of the Commonwealth · NIH-11164724 · Data updated 2026-11-12

This study is looking at how a protein called IL-13 affects the cells in the esophagus of people with eosinophilic esophagitis (EoE), which could help us find new ways to understand and diagnose this condition better.

More Eosinophilic Esophagitis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTemple Univ of the Commonwealth
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startAugust 15, 2024
Project endMay 31, 2028
Funding year2025
Award (this year)$689,971
NIH project number5R01DK136987-02
Project IDNIH-11164724 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with eosinophilic esophagitis, particularly those experiencing severe symptoms related to food allergies.

Less likely to help

Patients without eosinophilic esophagitis or those whose condition is unrelated to mitochondrial function may not benefit from this research.

What this research studies

This research focuses on eosinophilic esophagitis (EoE), a chronic condition driven by food allergies and immune responses. It examines how the protein interleukin-13 (IL-13) affects mitochondrial function in esophageal cells, potentially leading to inflammation and tissue changes. The study aims to uncover the molecular mechanisms behind these effects and explore the possibility of using mitochondrial changes as biomarkers for EoE. Patients may benefit from a better understanding of their condition and new diagnostic tools.

Why it matters

Potential benefit: If successful, this research could lead to improved diagnostic methods and targeted therapies for patients with eosinophilic esophagitis.

How similar studies have gone: Previous research has shown promising results in understanding the role of IL-13 in eosinophilic esophagitis, but the specific focus on mitochondrial biology is a novel approach.

Where this research is happening

  • Temple Univ of the Commonwealth
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Whelan, Kelly a — Temple Univ of the Commonwealth
  • Study coordinator: Whelan, Kelly a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.